Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, March, 2009 - PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period December 2008 to February 2009 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period December 2008 to February 2009 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AstraZeneca RECENTIN Recurrent glioblastoma multiforme and colorectal cancer IMC Medical Communication
AstraZeneca ZD4054 Prostate cancer IMC Medical Communication
Baxter Europe Advate and FEIBA Haemophilia Ashley Communications
Napp Pharmaceuticals Targinact   
Pain
Flutter & Wow
Novartis
Exelon patch
Neuroscience
Just::
Novartis
Stalevo
Neuroscience
Just::
Sanofi-aventis/ Bristol-Myers Squibb n/a Cardiovascular Medaxial
SPD Development Company Clearblue digital pregnancy test with conception indicator Women's health IMC Medical Communication
 Wyeth  ReFacto Haemophilia ROAD 

  

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

1st April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

OPEN Health Graduates and the XP Support Group
During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...
Alexander Devine Website has gone live!
As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics